(Q38166802)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24283604%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

title

Current and future evidence-based acne treatment: a review (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24283604%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24283604%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

author name string

Laura F Sandoval

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24283604%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Jennifer K Hartel

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24283604%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

language of work or name

English

0 references

publication date

27 November 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24283604%20AND%20SRC:MED&resulttype=core&format=json

Expert Opinion on Pharmacotherapy

1 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24283604%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

volume

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24283604%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24283604%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

page(s)

173-192

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24283604%20AND%20SRC:MED&resulttype=core&format=json

Epidemiology of acne vulgaris

1 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2014.860965

New insights into the management of acne: an update from the Global Alliance to Improve Outcomes in Acne group

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2014.860965

Tretinoin microsphere gel 0.04% pump for treating acne vulgaris in preadolescents: a randomized, controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2014.860965

Clinical and histological evaluation of 1% nadifloxacin cream in the treatment of acne vulgaris in Korean patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2014.860965

Topical nadifloxacin 1% cream vs. topical erythromycin 4% gel in the treatment of mild to moderate acne.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2014.860965

New developments in our understanding of acne pathogenesis and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2014.860965

Cortexolone 17α-propionate 1% cream, a new potent antiandrogen for topical treatment of acne vulgaris. A pilot randomized, double-blind comparative study vs. placebo and tretinoin 0·05% cream

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2014.860965

Oxidative stress in acne vulgaris.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2014.860965

Improvement of acne vulgaris by topical fullerene application: unique impact on skin care.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2014.860965

Sodium L-ascorbyl-2-phosphate 5% lotion for the treatment of acne vulgaris: a randomized, double-blind, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2014.860965

Resveratrol-containing gel for the treatment of acne vulgaris: a single-blind, vehicle-controlled, pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2014.860965

Clinical considerations on the use of concomitant therapy in the treatment of acne

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2014.860965

Combination of azelaic acid 5% and clindamycin 2% for the treatment of acne vulgaris

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2014.860965

Combination of azelaic acid 5% and erythromycin 2% in the treatment of acne vulgaris.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2014.860965

Oral isotretinoin in different dose regimens for acne vulgaris: a randomized comparative trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2014.860965

Effectiveness of conventional, low-dose and intermittent oral isotretinoin in the treatment of acne: a randomized, controlled comparative study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2014.860965

Low-cumulative dose isotretinoin treatment in mild-to-moderate acne: efficacy in achieving stable remission

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2014.860965

Aqueous extract of dried fruit of Berberis vulgaris L. in acne vulgaris, a clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2014.860965

An observational study of methionine-bound zinc with antioxidants for mild to moderate acne vulgaris

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2014.860965

Long-term efficacy and safety of a monophasic combined oral contraceptive containing 0.02 mg ethinylestradiol and 2 mg chlormadinone acetate administered in a 24/4-day regimen

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2014.860965

A fixed-dose combination of adapalene 0.1%-BPO 2.5% allows an early and sustained improvement in quality of life and patient treatment satisfaction in severe acne

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2014.860965

Acne: effect of hormones on pathogenesis and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2014.860965

The truth behind this undeniable efficacy--recurrence rates and relapse risk factors of acne treatment with oral isotretinoin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2014.860965

Topical retinoids in acne--an evidence-based overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2014.860965

SIG1273: a new cosmetic functional ingredient to reduce blemishes and Propionibacterium acnes in acne prone skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2014.860965

Comparison of tretinoin 0.05% cream and 3% alcohol‐based salicylic acid preparation in the treatment of acne vulgaris

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2014.860965

A study of the efficacy of cleansers for acne vulgaris

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2014.860965

Efficacy of oral antibiotics on acne vulgaris and their effects on quality of life: a multicenter randomized controlled trial using minocycline, roxithromycin and faropenem.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2014.860965